Mitochondrial DNA (mtDNA) mutations cause heterogeneous disorders in humans.
Introduction
The respiratory chain is the major source of the transmembrane electrochemical gradient utilized in mitochondria to generate ATP. In mammals, mitochondria contain multiple copies of a circular DNA molecule (mtDNA), which encodes for 13 protein components of the respiratory chain and a full complement of tRNAs and rRNAs necessary for mitochondrial protein translation (1) .
The structural models explaining the supramolecular organization of the respiratory chain have changed over the past decades. The initial one was the "solid state" model proposed by Chance and Williams (2) . This model has later been replaced by the "liquidstate" one, where functionally active individual complexes are free to diffuse laterally in the lipid bilayer of the inner membrane (3). In the "random collision model", (4, 5) , mitochondrial electron transfer depends on the random contacts between independent complexes and small diffusible molecules, such as coenzyme Q and cytochrome c. Only recently, the development of blue native gel electrophoresis has allowed for the identification of supramolecular structures containing multimers of respiratory chain complexes, in yeast and mammalian mitochondria, which are reminiscent of the original "solid-state" model (6) (7) (8) . Furthermore, the architecture of mammalian respiratory chain supercomplexes has been determined by a combined electrophoretic and single particle image analysis approach (9) . Flux control ratio studies on bovine mitochondria demonstrated that the respiratory chain is functionally organized in partial supercomplexes (10) . To date, however, it remains unclear to what extent the oxidative function of the respiratory chain is dependent upon the formation of supercomplexes.
In humans, mutations in mitochondrial genes cause metabolic disorders biochemically characterized by respiratory chain defects (11) . Pathogenic mtDNA mutations often coexist with wild type (WT) mtDNA within the same cells, a condition called mtDNA heteroplasmy. In this case, the degree of respiratory chain impairment depends on the relative proportions of mutant and WT mtDNA, with a clear threshold effect, which varies among cell types, based on the metabolic requirements for ATP. WT mtDNA can complement the loss of function of mutant mtDNA up to a certain threshold.
To complement the deleterious effects of the mutations, WT mtDNA, mtRNA, and mtDNA-encoded proteins must be able to diffuse within mitochondria. A more complex situation occurs when different mtDNA species are segregated within different mitochondria, because in this case complementation requires exchange of factors across the boundaries of mitochondrial membranes. In mammalian cells, mitochondria are organized in a dynamic network, which is subject to a constant reshaping process modulated by fusion and fission events (recently reviewed in (12) ). This reshaping process is likely to provide the mechanism whereby molecules are exchanged among mitochondria, allowing for functional complementation.
Cell hybridization models have been used to confirm the hypothesis that mitochondria can fuse to provide complementation. When cells containing homoplasmic levels of mutant mtDNA (i.e, 100% mutant mtDNA) and severely compromised respiratory function are fused with cells containing WT mtDNA, respiration is restored in the resulting hybrid cells (13) . Furthermore, the fusion of two cell lines, each containing a distinct homoplasmic mt-tRNA mutation, resulted in restored respiration, suggesting that tRNAs were exchanged among mitochondria (14) .
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To date, functional complementation between mitochondria containing mutations in polypeptide-coding genes has not been explored. To address this issue, we have investigated complementation between two human cell lines, each containing a homoplasmic mtDNA mutation in a gene encoding a subunit of distinct respiratory chain complexes. Both mutations result in a complete loss of their respective complexes. We have characterized the biochemical properties of protein-protein complementation in hybrids derived from fusion of these mutant cell lines. We have studied the direct effects of protein mutations on the assembly of individual respiratory chain complexes and on supermolecular complex formation, as well as the secondary effects on the assembly and function of complexes that are not directly affected by the mutations.
Results

Fusion of cybrids containing two distinct mutant mtDNA results in hybrids with restored respiratory chain functions.
Hybrids clones were obtained by fusion of two human osteosarcoma cybrid lines, one containing a homoplasmic stop-codon mutation in the cytochrome c oxidase subunit 1 gene (MTCO1), denoted as COX1-MT, and the other a frame-shift mutation in the gene encoding cytochrome b (MTCyB), denoted as CyB-MT. Both parental cybrids completely lacked mitochondrial respiration (15, 16) . Each cybrid line was engineered with a specific antibiotic resistance (i.e., hygromycin and puromycin, respectively), allowing for the double-selection of hybrid clones (nuclear complementation). Upon fusion, hybrids contained a mixture of variable proportions of the two mutant mtDNAs. In addition, because mtDNA recombination occurs between the two mtDNA alleles, new molecules of wild type (WT) mtDNA are formed (17) . Therefore, in most clones, the sum of the two mutant alleles does not account for 100% of the mtDNA molecules (see figures 4, 5, and 6).
To assess whether selective growth pressure has a significant impact on the frequency of hybrid clones, cybrid fusion was performed under different growth conditions. The clone frequency in non-selective medium, containing glucose, pyruvate, and uridine, reflects the efficiency of nuclear complemetation. The clone frequency in selective media lacking pyruvate and uridine (18) , or containing galactose instead of glucose as the major carbon source (19) , reflects the frequency of both nuclear and mitochondrial complementation, because these selective conditions only allow for survival of clones with restored mitochondrial respiratory chain activity. There is a small but statistically significant difference in the number of hybrid clones obtained in non-selective and mitochondrial selective conditions (Fig. 1A) . This indicates that the majority of the hybrids that survived the nuclear selection can also survive under mitochondrial selection, and suggests that cybrid fusion results both in nuclear and mitochondrial complementation. In all of the following experiments, we have studied hybrid clones that are able to survive in selective medium. Because in the literature there are a few examples of nuclear suppression of mtDNA defects (20, 21) , as a control, COX1-MT cybrids were also fused with cells devoid of mtDNA (ρ 0 cells) and resistant to neomycin.
As expected, the resulting COX1-MT-ρ 0 hybrids obtained by hygromycin and neomycin selection did not yield any viable clone under mitochondrial selective conditions (not 7 shown), suggesting that the hybridization procedure per se does not afford survival under mitochondrial selection.
Next, we investigated the growth of hybrid clones in galactose medium, as an indirect estimate of oxidative phosphorylative function. On average, the number of hybrid cells counted after three days of growth in galactose is approximately 60% lower than WT cells (Fig. 1B) . The wide variability suggests that individual clones have varying levels of respiratory chain recovery. As expected, both parental cybrids fail to grow in galactose medium. Oxygen consumption measurements confirm that mitochondrial respiration is restored in hybrid cells. However, on average, coupled respiration in intact cells is lower in hybrid cells than in WT controls, with a wide variation (Fig. 1C) . Cell respiration uncoupled with FCCP, which generates the maximal respiratory chain activity in intact cells, follows a similar trend (Fig. 1D ). As expected, parental cybrids have no respiratory activity, either in coupled or uncoupled conditions (Fig. 1C,D) .
Correlation between mtDNA mutation levels, specific enzyme activities, and respiration, in hybrid cells.
In figure 2A , the relative abundance of each of the two mutant mtDNA species is correlated with cell respiration. Because the proportions of each heteroplasmic mutant mtDNA species varied in the same clone over time, the levels of both mutations have been measured after each experiment. From the tri-dimensional plot, it is apparent that a number of clones have respiration similar to WT cells. These clones contain variable proportions of the two mutant mtDNAs, but in each clone these proportions were below 40% and 90% for COX1-MT and CyB-MT, respectively. All the clones with proportions 8 of mutant mtDNA above these levels had defective respiration. The 40% threshold for COX1-MT was in agreement with the one that we had previously reported in cybrids containing only COX1-MT mtDNA (16) . Because the threshold for CyB-MT had not been established previously, we have looked at the correlation between the proportion of CyB-WT and cell respiration. The plot in figure 2B shows hybrid clones with high proportions of COX1-WT, above 60% (i.e., above the threshold for respiratory defect), and variable proportions of CyB-WT. The data points were interpolated with the equation (Fig. 1B) . It is likely that hybrids with very high proportions of mutant mtDNA, close to 100%, are unable to complement and do not survive the metabolic selection, which may explain why a decrease in clone numbers is observed under these conditions (Fig. 1A) .
To study the correlation between mutation loads and activities of respiratory chain complexes, we measured complex IV and complex III specific activities using exogenous substrates. There is no threshold for these specific activities, because they both show an inverse linear correlation with the proportions of their respective mutations (Fig. 2C,D ).
This suggests that both mutations affect the respective complex activities by decreasing the total amount of assembled active enzymes, without decreasing their intrinsic kinetic 9 parameters. It also excludes the possibility that CyB-MT affects complex IV activity and vice versa, because in this case the correlations would not be linear.
Respiratory chain complex assembly in human cybrid cells.
To understand the effects of the mtDNA mutations on the composition of the respiratory chain we have investigated the assembly of its complexes by blue native gel electrophoresis. We first determined the appropriate conditions to solubilize mitochondrial membranes while preserving intact respiratory chain complexes. We tested supercomplex has been previously demonstrated in mammalian cells (22) . The relative proportion of this III 2 +IV complex appears to increase with progressive solubilization with lauryl maltoside (Fig. 3A) , suggesting that the interactions between the components of complex III and IV are strong, and not completely disrupted by the solubilization.
To confirm that the high migrating bands observed in the digitonin treated samples correspond to supercomplexes containing multimers of the various respiratory chain enzymes, the same WT cybrid sample was loaded side-by-side in four adjacent wells.
After electrophoresis and blotting, each lane was cut and probed with an antibody against subunits of different complexes. As expected, using antibodies against complexes I, III, and IV, at least one band migrating at a common position can be detected (band 1 in figure 3B ), whereas complex V and complex II migrate at different positions because they are not part of the same supercomplex. In addition to the common supercomplex band, COX1 antibodies also reveal the 200 KDa monomeric complex IV plus three high migrating bands (bands 2-4 in figure 3B ), which presumably correspond to supercomplexes containing variable numbers of complex IV, as previously reported by Schägger and colleagues (7). These three higher migrating bands are better detected with the COX1 antibody than with antibodies against the other complexes, possibly because complex IV subunits are the most abundant or because epitopes for the other complexes may be partially masked in these high molecular weight structures.
In order to ensure that digitonin solubilizes mitochondrial membranes similarly in WT and mutant cells a digitonin titration was performed in control and in 100% mutant COX1 or CyB parental cybrids. We looked at complex II by blue-native western blot, because this complex is not affected directly or indirectly by either mutation. As expected, decreasing digitonin below 0.3 % had similar effect on the solubility of complex II in all cell lines (Fig. 3C ).
The assembly of the respiratory chain complexes is defective in hybrid cells.
The amounts of assembled respiratory chain complexes in hybrid clones were estimated using blue native gel electrophoresis of mitochondrial proteins solubilized with 0.4% lauryl maltoside. Compared to WT cybrids, mutant hybrids show loss of complex III and IV, which worsens with increasing CyB-MT or COX1-MT loads, respectively (Fig. 4A ). In addition, the supercomplex III 2 +IV is reduced as compared to WT cells in hybrid clones containing levels of mutant mtDNA above the threshold for defective respiration (40% and 90%, for COX1-MT and CyB-MT, respectively). Interestingly, in some clones, there is a loss of complex I, which is not genetically affected by the two mutations. Complex I defect is most pronounced in the clones with the highest proportions of either COX1-MT (51%) or CyB-MT (96%). Complex II is unaffected by the mtDNA mutations and, therefore, was used to normalize the levels of the other complexes in figure 4 . We also studied the levels of assembled complexes in the parental homoplasmic mutant cybrids (Fig. 4B) . In COX1-MT cybrids, there is a complete lack of complex IV and supercomplex III 2 +IV, while complex I is decreased by approximately 30%. In CyB-MT cybrids, there are no complex III and III 2 +IV, and complex I is severely decreased by approximately 90%. Complex III is not decreased in COX1-MT cybrids and complex IV is not decreased in CyB-MT cybrids, suggesting that the assembly of complexes III and IV are independent from each other. Note that, in CyB-MT and COX1-MT homoplasmic cybdrids, the levels of complexes IV and III respectively appear higher than in wild type cells. This is because, unlike wild type cells, the supercomplex III 2 +IV cannot form in mutant cybrids, and each complex is resolved in an individual band. In-gel complex I activity is reduced in the hybrid clones and in the parental mutant cybrids as compared to wild type cells, consistent with the decrease of assembled complex I (Fig. 4C,D) . To confirm that cells containing high levels of COX1-MT mtDNA have reduced complex I, we also studied heteroplasmic cybrid COX1-MT cells. Clones with mutation levels above 90% have a clear reduction of complex I, whereas a clone with 33% mutant mtDNA shows normal complex I content (Fig. 4E) .
Recovery of supercomplex assembly correlates with recovery of mitochondrial respiratory function, in hybrid cells.
The proportion of mutant mtDNA correlates with the levels of their respective enzymatic activities (Figs. 2C,D) . However, they are not linearly correlated with mitochondrial respiration (Fig. 2A) . Therefore, we have investigated whether respiration is dependent on the presence of respiratory chain supercomplexes. Mitochondrial membranes are solubilized with 0.33% digitonin to preserve supercomplex integrity. The high molecular weight bands, corresponding to a multimeric structure composed of complexes I+III 2 +IV (1) (2) (3) (4) are clearly detectable in the representative clones c and d shown in figure 5A , which have very low amounts of individual III 2 and IV. In these clones the proportions of both mutations are below the threshold for respiratory defect ( Fig. 2A) .
Conversely, hybrid clones a and b, in which CyB-MT mtDNA is above the threshold (i.e., above 90%, fig. 2A,B) , have very reduced levels of supercomplexes I+III 2 +IV (1) (2) (3) (4) .
As a comparison, WT cybrids show the presence of supercomplexes as well as individual complexes III 2 , IV, and III 2 +IV (Fig. 5A ). Homoplasmic CyB-MT cybrids with no complex III 2 have a complete lack of supercomplexes, but contain individual complex IV.
In contrast, hybrid clone e, which contains COX1-MT mtDNA above the respiratory defect threshold (i.e., above 40%) has no individual complex IV, but a large amount of III 2 (Fig. 5A) , suggesting that all the available complex IV is part of a supercomplex, whereas most of complex III is in its dimeric form. In this clone, the reduced amount of complex IV available is sufficient for the formation of I+III+IV with stochiometry 1:2:1 or 1:2:2, but not of supercomplexes with complex IV stochiometry higher than 2. This is not readily apparent in the blot in figure 5A (long exposure), but it is better demonstrated in figure 5B , where gel running conditions are optimized to resolve the high molecular figure 6A (top panel). We find a linear inverse correlation between the proportion of CyB-MT mtDNA and complex III content (Fig. 6B ). This result was expected, based on the linear inverse correlation between the proportion of CyB-MT mtDNA and complex III activity shown in figure 2C . However, the correlation between complex III content and respiration is not linear (Fig. 6C) . Instead, we observe a hyperbolic curve similar to that describing the correlation between the proportion of CyB-MT mtDNA and respiration (Fig. 2B ). This type of correlation curve suggests that a respiration defect occurs only when complex III content falls below approximately 10% of normal. In the clones tested, a decrease in respiration appears to be associated with a marked decrease of supercomplex content (Fig. 6A lower panel) . Clones with CyB-MT mtDNA below 90% have normal respiration and abundant supercomplex (right lanes), whereas clones above 90% have reduced respiration and very low or undetectable supercomplex (left lanes).
Discussion
Functional complementation between mitochondria containing pathogenic tRNA mutations has been demonstrated previously (13, 14, 23) , although one report suggests that it may be a rare event (24) . Here, we demonstrate complementation resulting from exchange of mtDNA-encoded polypeptides among mitochondria. We show that complementation of respiratory chain function occurs in hybrid clones containing a mixture of two pathogenic mutations in polypeptide-coding genes, COX1 and CyB.
Metabolic selection in conditions that only allow for survival of cells with respiratory chain function (i.e., uridine and pyruvate deprivation or galactose medium) decreases the number of hybrid clones only by 25% (Fig. 1A) . This indicates that complementation of mtDNA proteins is a frequent event following cell hybridization, and that diffusion of molecules within fused organelles is very efficient. Rapid and efficient exchange of proteins in the matrix of fused mitochondria has been clearly demonstrated, and membrane potential is necessary for this process (25) . The parental cybrids used in this study have no residual respiratory chain function. However, it is likely that they can maintain a mitochondrial membrane potential sufficient for fusion by intramitochondrial hydrolysis of glycolytic ATP (26) .
Although all selected hybrid clones show restored respiratory functions, the degree of complementation is very variable (Fig. 1B-D) . The level of the recovery of respiration depends on the proportions of wild type COX1 and CyB genes present in each hybrid clone. The correlation between mutation load and respiration shows a clear threshold effect, which differs for the two mutations: hybrid cells are able to tolerate a much higher proportion of mutant CyB than mutant COX1 before showing a decrease in respiration ( Fig. 2A and (16) We show a decrease in the levels of complex I in the hybrid clones containing high levels of CyB-MT or COX1-MT mtDNA (Fig. 4A,C) ). Complex I stability has been shown to depend on the levels of complex III in various organisms, including bacteria (27) and mammalian cells (8, 28, 29) . Here, we confirm this finding, but we also show for the first time that complex I stability can also be affected by complex IV, in human cells, although high COX1 mutation levels are needed to observe destabilization of complex I, (Fig. 4) . In addition, the mutation level necessary to observe this phenomenon could vary in different cell types, because muscle cells from patients with nuclearencoded complex IV defects, which contain only 10% of normally assembled complex IV, do not show a marked reduction of complex I (8, 30) . These variations could be associated with the different rates of turnover of mitochondrial respiratory chain complexes in different cell types.
It was shown that the synthesis of complex I subunits and their assembly occur normally in complex III mutant cells, but in the absence of complex III complex I is rapidly degraded (28) . This indicates that complex III may act as a chaperone that stabilizes complex I and, based on our data, complex IV may further stabilize the supercomplex. Because I+IV intermediates are never detected, the interactions between complexes I and IV are probably indirect through complex III. A supercomplex I+III 2 can form in the absence of complex IV (Fig. 5A) , and a stable supercomplex III 2 +IV is observed after solubilization with lauryl maltoside (Fig. 4A) . These are likely to be supercomplex assembly intermediates, perhaps forming assembly cores for the addition of complex I and complex IV. On the other hand, it appears that fully assembled complex I is not necessary for the assembly and stability of complexes III and IV (8) There are several potential advantages to a supramolecular organization of the respiratory chain. For example, it is possible that such structures allow for a more efficient utilization of available substrates and cofactors than in a random collision model. It is also possible that they decrease the probability of electron escape to generate reactive oxygen species (8) . In hybrid cells, complex I, the principal source of free radicals through semiquinone (33) , is always associated with complexes III and IV ( Fig.   5 ), possibly to prevent excessive free radical production.
In conclusion, this study of COX1-MT and CyB-MT hybrid human cells provides novel clues for understanding the functional structures underlying mitochondrial respiration and the mechanisms that modulate the biochemical and clinical phenotypes in mitochondrial disorders. We suggest that the presence of supercomplexes sets the threshold for functional complementation. Therefore, the ability to form sufficient levels of supercomplexes emerges as one of the critical steps modulating the expression of mitochondrial diseases associated with mutations in the respiratory chain subunits.
Materials and methods
Cell culture
Parental COX1-MT and CyB-MT cybrid lines were cultured in Dulbecco's Modified
Eagle's medium (DMEM, Invitrogen) containing 4.5 g/L glucose, 110 mg/L pyruvate, 50 µg/ml uridine (medium A) supplemented with 10% fetal bovine serum (FBS, Cellgro).
Cell fusions and nuclear selection of hybrid cells were performed using 50% (w/v) polyethylene glycol (ATCC) and a combination of puromycin (Sigma-Aldrich) and hygromycin (Invitrogen) as described (17), in medium A.
For metabolic selection, 14 days after fusion, hybrid clones were grown in triplicate plates with mitochondrial selection media. Selection medium B contained 4.5 g/L galactose, 110 mg/L pyruvate, and 50 µg/ml uridine (all from Sigma-Aldrich). Selection medium C contained 4.5 g/L glucose, no pyruvate and no uridine. Both media B and C were supplemented with 10% dialyzed FBS. One week later (21 days after fusion), the number of surviving hybrid clones was counted in triplicate plates for each of the selection conditions. In addition, a portion of the hybrid clones selected in medium C were collected by the cylinder method (18), cultured in the same medium, and used for further studies.
Respiratory chain analyses
Growth of hybrids clones in galactose (medium B) was determined by plating 100 x 10 3 cells in 9 x 35-mm plastic Petri dishes. Cells were counted in triplicate daily, for three consecutive days.
Oxygen consumption was measured on intact cells using pyruvate as substrate, with or without the protonophore carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP, 2 µM, Sigma-Aldrich), in a thermostatic oxygraph chamber equipped with a Clark-type electrode (Hansatech) as described (16) . The CyB-MT mtDNA threshold for respiration defect was obtained with a non-linear regression fitting curve, using the application program SigmaPlot (Sigmaplot Scientific Graphing Software, Version 9.01).
Enzymatic assays of respiratory chain complex activities were performed on isolated mitochondria obtained from 10 semi-confluent 150-mm dishes (approximately 100-150 x 10 6 cells) as described (34) . The activities of complex III, IV and citrate synthase were measured by spectrophotometric assays as described (34, 35) .
For complex I in-gel activity assay samples were separated by blue native gel electrophoresis and incubated in 2mM Tris-HCl, pH 7.4, 0.1 mg/ml NADH (SigmaAldrich), and 2.5 mg/ml nitrotetrazolium blue (NTB, Sigma-Aldrich). After overnight incubation at room temperature, the stained gel was washed in distilled water and imaged with a digital scanner.
MtDNA analyses
The relative proportions of COX1-MT and CyB-MT mtDNA species were determined in each hybrid clone by PCR-RFLP (restriction fragment length polymorphism) analysis of digested radiolabeled products, as described (17) .
Blue native electrophoresis
Mitochondrial membranes were isolated from 2.5 x 10 6 cells as described (36) .
Various concentrations of two different detergents were tested to optimize the solubilization of mitochondrial proteins: lauryl maltoside (Sigma-Aldrich) from 0.01% to 0.4% (w/v), and digitonin (Sigma-Aldrich) from 0.3% to 5% (w/v). 10 µl of sample were loaded on a 5-13% gradient polyacrylamide gel. Electrophoresis was performed as described (36) . Transfer of proteins onto a PVDF membrane (BioRad) was carried out overnight at 30V, at 4ºC. For immunodetection of protein complexes, monoclonal antibodies (Invitrogen) against the following subunits were used: 39KDa of complex I, 70KDa of complex II, core 2 of complex III, subunit I of complex IV, subunit β of complex V. Native high molecular weight markers were from Amersham Biosciences.
For second dimension gel electrophoresis, a lane excised from the first dimension native gel was first treated with denaturing buffer containing 15 mM β-mercaptoethanol, 1% SDS for 30 minutes and then washed in 1% SDS for 1 hour. The gel strip was then electrophoresed on a tricine-SDS-polyacrylamide gel as described (37) . 
